SC 13G
ADIAL PHARMACEUTICALS, INC.
- Company
- ADIAL PHARMACEUTICALS, INC.
- Filed
- March 1, 2019
- Accession Number
- 0000902664-19-001327
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →